NCT02854982

Brief Summary

To study the quality of life of patients with prostate cancer at a distance from their care at a time when they are supposed to have taken a "normal" life and compared to subjects without cancer prostate of the same age.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
900

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Sep 2015

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2015

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

August 1, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 4, 2016

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2017

Completed
Last Updated

November 21, 2025

Status Verified

August 1, 2018

Enrollment Period

1.9 years

First QC Date

August 1, 2016

Last Update Submit

November 18, 2025

Conditions

Prostatic NeoplasmsQuality of Life

Outcome Measures

Primary Outcomes (1)

  • EORTC Quality of Life Questionnaire - Core 30 Score (EORTC QLQ-C30 Score)

    3 years from diagnosis for cases of prostate cancer and from recruitment for controls

Study Arms (2)

Prostate Cancer

Group drawn of the case group of the case control study, entitled EPICAP

Procedure: therapeutic management of the prostate Cancer as usual

No Prostate Cancer

Group drawn of the control group of the case control study, entitled EPICAP

Interventions

therapeutic management of the prostate Cancer as usualPROCEDURE
Prostate Cancer

Eligibility Criteria

AgeUp to 75 Years
Sexmale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Target population: incident cases of prostate cancer

You may qualify if:

  • prostate cancer diagnosed from 1 December 2011 to 31 December 2014
  • under 75 and residing in the Hérault department at diagnosis
  • recruited in the EPICAP study

You may not qualify if:

  • having relapsed in the range
  • non-exposed group:
  • controls (without prostate cancer) recruited in the EPICAP study
  • matched to cases on age (5 years)
  • residing in the Hérault department
  • diagnosis of prostate cancer set in the range

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Houede N, Rebillard X, Bouvet S, Kabani S, Fabbro-Peray P, Tretarre B, Menegaux F. Impact on quality of life 3 years after diagnosis of prostate cancer patients below 75 at diagnosis: an observational case-control study. BMC Cancer. 2020 Aug 12;20(1):757. doi: 10.1186/s12885-020-07244-y.

    PMID: 32787797RESULT

MeSH Terms

Conditions

Prostatic Neoplasms

Condition Hierarchy (Ancestors)

Genital Neoplasms, MaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsGenital Diseases, MaleGenital DiseasesUrogenital DiseasesProstatic DiseasesMale Urogenital Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 1, 2016

First Posted

August 4, 2016

Study Start

September 1, 2015

Primary Completion

July 31, 2017

Study Completion

July 31, 2017

Last Updated

November 21, 2025

Record last verified: 2018-08